R17K (p.Arg17Lys) variant of REL (Proto-oncogene c-Rel)
R17K (p.Arg17Lys) in REL (Proto-oncogene c-Rel) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
R17K (p.Arg17Lys) variant details
- p.Arg17Lys
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available